Five-Year Registration Validity and Renewal Window in Macao

Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

Medical device registration in Macao, China is valid for 5 years, counted from the date of issue of the registration certificate. The renewal application must be filed within the interval from 90 to 180 days before expiry — a window closed at both ends: applications filed earlier than 180 days are not accepted, and filing later than 90 days means the renewal deadline has been missed. The review and decision on renewal follow the procedure laid down in Administrative Regulation No. 11/2026, with the specific requirements set out in Dispatch No. 10/ISAF/2026. Filing has no validity period, which is a structural advantage of the filing channel for Class I and Class IIa devices compared with the registration channel.

  • Registration is valid for 5 years from issue of the certificate.
  • Renewal applications are accepted only between 90 and 180 days before expiry.
  • The formal review takes 20 working days; decisions take 70 working days for Class IIb and 100 working days for Class III, extendable by 45 working days.
  • Filing has no validity period, so no renewal window applies to Class I and Class IIa devices.
  • Renewal is a substantive re-examination of continued compliance, not a stamp.

2. Legal basis

The validity and renewal framework rests on the parent law, the procedural provisions of the implementing rules, the renewal dispatch and the fee schedule. The table below lists the instruments and provisions cited in this article.

Regulatory instrumentReferencePublication dateProvisions
Medical Devices Regulatory RegimeLaw No. 12/2025 (Official Gazette No. 30/2025)Published on 28 July 2025; effective on 1 July 2026Article 9 (circulation subject to registration or filing); Article 20 (validity and renewal of registration: valid for five years, renewable for the same period); Article 16 (obligations of registration holders and filing holders)
Implementing Rules of the Medical Devices Regulatory RegimeAdministrative Regulation No. 11/2026 (Official Gazette No. 20/2026)Published on 18 May 2026; effective on 1 July 2026Article 18 (renewal of registration; 90 to 180 day window); formal review provision (20 working days); decision period provision (Class IIb 70 working days, Class III 100 working days, extendable by 45 working days)
Technical Requirements and Specific Rules for Renewal of Medical Device RegistrationDispatch No. 10/ISAF/2026Published in 2026; effective on 1 July 2026Full text of the dispatch
Dispatch of the Chief Executive No. 144/2026 approving the Fee Schedule for Medical Device Business Activities and Medical Device RegistrationDispatch of the Chief Executive No. 144/2026 (Official Gazette No. 24/2026)Published on 15 June 2026; effective on 1 July 2026Table 2 (registration renewal MOP 200; reissue of the registration certificate MOP 200)

3. Expert insights

Insight one: 90 to 180 days is an interval, not a minimum of 90 days. In many markets the renewal rule reads within X months before expiry; in Macao the wording is within 90 to 180 days before expiry, with both an upper and a lower limit. This creates a practical trap: a company that prepares and submits its dossier more than half a year in advance will find the application not accepted because it is too early. Practical estimate: it is advisable to anchor the submission at around 150 days before expiry, staying clear of the upper limit while leaving margin for corrections.

Insight two: renewal also passes through a formal review and a substantive review. The formal review takes 20 working days, and the decision period is 70 working days for Class IIb or 100 working days for Class III, extendable by up to 45 working days. Adding these segments together, renewal of a Class III device can approach 165 working days — which means that filing within the window does not guarantee holding the new certificate before expiry. Companies must prepare a contingency plan for the gap in which the old certificate has expired but the new one has not yet been issued.

Insight three: filing has no validity period and is a long-term entry ticket. Class I and Class IIa devices go through the filing channel, and filing has no validity period, so no renewal window applies. But this does not mean it is maintenance-free — changes to the filing information, products no longer meeting quality standards, or cancellation of the filing holder all affect the validity of the filing.

Insight four: renewal is an opportunity for the ISAF to re-examine the compliance status of the product. Renewal is not a formal stamping exercise; the registration holder must demonstrate that the product has continuously met the statutory requirements during the validity period, including quality standards, adverse event experience and post-market study results. Where a serious adverse event, a recall or a risk control measure occurred during the validity period, these become focal points of the renewal review.

Insight five: validity and the transitional period are two independent timelines. The transitional period addresses when devices already on the market must complete registration; validity addresses how an obtained registration is maintained. During the 2026-2032 transitional period, companies may be pulled by both timelines at once — first completing initial registration under the transitional arrangements, then entering the renewal cycle on the 5-year rhythm. The two must not be conflated in scheduling.

4. Practical recommendations

  • Maintain a certificate ledger with dual reminders: start preparation 180 days before expiry and submit by 150 days before expiry.
  • Plan backwards from the longest cycle: for Class III devices calculate on the basis of 165 working days and prepare a contingency plan for the gap period.
  • Maintain renewal documentation a year in advance: archive post-market surveillance, adverse event and change records continuously.
  • Run annual self-assessment for filing holders too: no validity period does not mean no obligations.
  • Manage certificates centrally at group level: avoid missed deadlines caused by multiple entities and products acting in isolation.

5. Verification checklist

  • □ Issue date of the registration certificate and the 5-year expiry date entered in the ledger
  • □ Renewal submission anchored within the 90 to 180 day interval before expiry
  • □ Formal review of 20 working days built into the schedule
  • □ Decision period of 70 (Class IIb) and 100 (Class III) working days and the 45 day extension built into the schedule
  • □ Renewal documents required by Dispatch No. 10/ISAF/2026 completed
  • □ Renewal fee of MOP 200 included in the budget
  • □ Contingency plan for the gap period (old certificate expired, new certificate not issued) prepared
  • □ Annual self-assessment mechanism for filing products established

Regulatory information verified as of 29 October 2026. The laws, guidelines and effective dates described in this article are limited to the content published by the official sources listed under Legal basis as of that date; where official documents are updated, the most recently published version prevails.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for Macao, China. Our team coordinates local licence holder arrangements, import and supply requirements, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail